Ruminant Feed Antibiotics Global Market Report 2024

The ruminant feed antibiotics market size has grown strongly in recent years. It will grow from $5.06 billion in 2023 to $5.53 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The expansion observed in the historical period can be attributed to the management of livestock diseases, improvements in feed efficiency, growth promotion, preventive measures in agriculture, and veterinary prescriptions and practices.

The ruminant feed antibiotics market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in the forecast period can be ascribed to regulatory changes and restrictions, an increase in the use of alternative feed additives, consumer demand for antibiotic-free products, concerns about health and welfare, and industry initiatives promoting sustainable agriculture. Key trends expected in this forecast period encompass a shift towards antibiotic alternatives, the adoption of precision feeding practices, a focus on gut health, regulatory changes driving reduction, and the implementation of nutritional support solutions.

The anticipated increase in the demand for dairy products is poised to drive the growth of the ruminant feed antibiotics market in the coming years. Dairy products encompass a range of foods derived from milk, including butter, cheese, ice cream, yogurt, and condensed and dried milk. The incorporation of antibiotics in ruminant feed is known to enhance animal performance, enabling farmers to achieve higher milk production with reduced feed input. Specifically, ruminant feed antibiotics are employed to stimulate milk production in dairy cows by promoting the production of essential compounds in the rumen bacteria colony, one of the four stomachs in ruminant cattle. According to data from the United States Department of Agriculture (USDA) in February 2022, the consumption of milk fat in the United States consistently increased throughout 2021, witnessing a total rise of 4.0 billion pounds on a milk-fat basis. Additionally, domestic consumption of cheese, milk fat, and skim milk solids experienced notable increases in 2021, contributing to the upward trajectory of the ruminant feed antibiotics market.

The escalating demand for meat and meat products is anticipated to be a driving force for the ruminant feed antibiotics market. Meat, referring to the flesh of animals consumed as food, and meat products, which are processed or prepared items made from meat, are key contributors to the market's growth. Ruminant feed antibiotics play a pivotal role in promoting growth and preventing diseases in livestock, thereby enhancing the efficiency of meat production. Notably, data from Veterinaria Digital S.A. in May 2022 revealed substantial imports of chicken meat by Asian countries, amounting to around $864 million and totaling 460,159 metric tons. This underscores the market's growth fueled by the increasing demand for meat and meat products.

A noteworthy trend gaining traction in the ruminant feed antibiotics market is product innovation, with major companies actively developing inventive solutions to fortify their market positions. An exemplary case is Charoen Pokphand Foods PCL, a Thailand-based agro-industrial and food business, which introduced a unique feed formulation in June 2021. This formulation incorporates microorganisms to enhance the digestive systems of farm animals, promoting strength and health without the use of antibiotics or growth hormones. Furthermore, the formulation boosts immunity, providing animals with protection against illnesses.

Major players in the ruminant feed antibiotics market are intensifying their focus on introducing broad-spectrum antibiotics to gain a competitive edge. Broad-spectrum antibiotics, effective against a wide range of bacteria, targeting both gram-positive and gram-negative species, are a strategic focus. For instance, in July 2022, Virbac, a France-based pharmaceutical company, expanded its livestock health product portfolio by launching Tenotryl (enrofloxacin) injectable solution in the United States. Tenotryl, a broad-spectrum antibiotic with FDA approval and 25 years of trust in the U.S. cattle and swine industry, is indicated for treating bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and swine respiratory disease (SRD) in swine, associated with various pathogens.

In August 2022, Elanco Animal Health Incorporated, a US-based pharmaceutical company, entered into a collaboration with Colorado State University's AgNext to advance livestock sustainability, encompassing ruminant feed antibiotics. This collaboration aims to accelerate sustainability innovations in animal agriculture by leveraging Colorado State's AgNext program, renowned for its research and innovation in animal and ecosystem health, alongside Elanco's existing capabilities. Colorado State University's AgNext is a U.S.-based research and innovation program focused on finding sustainable solutions for animal agriculture.

Major companies operating in the ruminant feed antibiotics market report are Elanco Animal Health Inc., Zoetis Inc., Merck And Co. Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale SA, Bayer AG, Virbac SA, Phibro Animal Health Corp, Vetoquinol S.A., BASF SE, Novartis AG, Eli Lilly & Co, Cargill Incorporated, Koninklijke DSM N.V., Huvepharma Inc., Nutreco N.V., Provimi Holding B.V., Land O'Lakes Inc., Balchem Corporation, Novus International Inc, Biomin Holding GmbH, Kemin Industries Inc, Chr. Hansen Holding A/S, Evonik Industries AG, Archer Daniels Midland Company, Lallemand Inc., Phileo by Lesaffre, Royal Agrifirm Group, Diamond V, Berg + Schmidt India Pvt. Ltd.

Asia-Pacific was the largest region in the ruminant feed antibiotics market in 2023. The regions covered in the ruminant feed antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ruminant feed antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The key varieties of ruminant feed antibiotics include tetracycline, penicillin, sulphonamides, macrolides, aminoglycosides, cephalosporins, and others. Tetracycline, for instance, is a medication employed in treating bacterial ailments such as pneumonia and other respiratory tract diseases. Typically bacteriostatic, the effective use of tetracyclines necessitates a responsive host defense mechanism. Various animals, including dairy cattle, beef cattle, and others, benefit from these antibiotics. Major end-users encompass dairy farms, veterinary hospitals, and other related sectors.

The ruminant feed antibiotics market research report is one of a series of new reports that provides ruminant feed antibiotics market statistics, including ruminant feed antibiotics industry global market size, regional shares, competitors with a ruminant feed antibiotics market share, detailed ruminant feed antibiotics market segments, market trends and opportunities and any further data you may need to thrive in the ruminant feed antibiotics industry. This ruminant feed antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.